IP Library Granted Patent US 9,714,219
Granted Patent B2
US 9,714,219 · App. 14/917,589 · Granted Jul 25, 2017

Sulfonylaminobenzamide compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,714,219
App. No.
14/917,589
Granted
Jul 25, 2017
Kind
B2
Abstract

The present invention relates to a new compound of formula (I) wherein the variables have the meaning as indicated in the claims; or an enantiomer or salt thereof. The compounds of formula (I) are useful in the control of parasites, in particular endoparasites, in and on vertebrates.

Claims (23)

1. A compound of formula

or a salt or an enantiomer thereof, wherein

X is O, S, NH, C(O), C(CN) or CH═CH;

R 0 is H, C 1 -C 4 -alkyl or hydroxyl;

n is 0 or 1;

each R is independently halogen; C 1 -C 6 -alkyl; C 1 -C 6 -haloalkyl; C 3 -C 6 -cycloalkyl; C 3 -C 6 -halocycloalkyl; amino; N-mono- or N,N-di-C 1 -C 4 -alkylamino; hydroxy; C 1 -C 6 -alkoxy; C 1 -C 6 -haloalkoxy; C 1 -C 6 -alkylthio; C 1 -C 6 -haloalkylthio; C 1 -C 6 -alkyl-sulfinyl; C 1 -C 6 -haloalkylsulfinyl; C 1 -C 6 -alkylsulfonyl; C 1 -C 6 -haloalkylsulfonyl; SF 5 ; tri-C 1 -C 4 -alkylsilyl; C 1 -C 6 -alkoxycarbonyl; aminocarbonyl; N-mono- or N,N-di-C 1 -C 6 -alkylaminocarbonyl; aminosulfonyl; N-mono- or N,N-di-C 1 -C 6 -alkylaminosulfonyl; N—C 1 -C 6 -alkylsulfonylamino; C 1 -C 6 -alkoxycarbonylamino; N-C 1 -C 4 -alkyl-N-C 1 -C 6 -alkoxycarbonylamino; cyano; nitro; or C 3 -C 6 -heterocyclyl which is unsubstituted or substituted by halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cyclolalkyl, C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, amino, cyano or nitro;

m is an integer from 0 to 4;

each R 1 is independently halogen; C 1 -C 6 -alkyl; C 1 -C 6 -haloalkyl; C 3 -C 6 -cycloalkyl; C 3 -C 6 -halocycloalkyl; C 1 -C 6 -alkoxy; C 1 -C 6 -haloalkoxy; C 1 -C 6 -alkylthio; C 1 -C 6 -haloalkylthio; C 1 -C 6 -alkyl-sulfinyl; C 1 -C 6 -haloalkylsulfinyl; C 1 -C 6 -alkylsulfonyl; C 1 -C 6 -haloalkylsulfonyl; SF 5 ; amino; N-mono- or N,N-di-C 1 -C 6 -alkylamino; tri-C 1 -C 4 -alkylsilyl; C 1 -C 6 -alkoxycarbonyl; aminocarbonyl; N-mono- or N,N-di-C 1 -C 6 -alkylaminocarbonyl; N,N-di-C 1 -C 4 -alkylamino-C 1 -C 4 -alkylaminocarbonyl; aminosulfonyl; N-mono- or N,N-di-C 1 -C 6 -alkylaminosulfonyl; N—C 1 -C 6 -alkylsulfonylamino; C 1 -C 6 -alkoxycarbonylamino; N—C 1 -C 4 -alkyl-N—C 1 -C 6 -alkoxycarbonylamino; cyano; nitro; hydroxy; B(OH) 2 ; or phenyl, benzoyl, C 3 -C 6 -heterocyclyl, C 3 -C 6 -heterocyclyloxy or C 6 -C 8 -benzoheterocyclyl, which is each unsubstituted or substituted by halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl; C 1 -C 4 -alkoxy, C 1 -C 4 -haloalkoxy, amino, cyano or nitro; and

r is an integer of from 1 to 4.

2. A compound of formula (I) according to claim 1 , wherein each R is independently halogen; C 1 -C 4 -alkyl; C 1 -C 4 -haloalkyl; amino; C 1 -C 4 -alkoxy; C 1 -C 4 -haloalkoxy; C 1 -C 4 -haloalkylthio; C 1 -C 4 -alkylsulfonyl; C 1 -C 4 -haloalkylsulfonyl; tri-C 1 -C 2 -alkylsilyl; C 1 -C 4 -alkoxycarbonyl; N-mono- or N,N-di-C 1 -C 4 -alkylaminocarbonyl; aminosulfonyl; N-mono- or N,N-di-C 1 -C 4 -alkylaminosulfonyl; N—C 1 -C 2 -alkyl-N—C 1 -C 4 -alkoxycarbonylamino; cyano; nitro; or 5- or 6-membered heterocycloalkyl comprising 1 or 2 same or different heteroatoms selected from O, S and N, which is unsubstituted or substituted by halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl or C 1 -C 2 -alkoxy.

3. A compound of formula (I) according to claim 1 , wherein each R is halogen, C 1 -C 2 -alkyl, C 1 -C 2 -haloalkyl, C 1 -C 2 -alkoxy, C 1 -C 2 -haloalkoxy or cyano.

4. A compound of formula (I) according to claim 3 , wherein m is an integer 1, 2 or 3.

5. A compound of formula (I) according to claim 4 , wherein each R 1 is independently halogen; C 1 -C 4 -alkyl; C 1 -C 4 -haloalkyl; C 3 -C 6 -cycloalkyl; C 1 -C 4 -alkoxy; C 1 -C 4 -haloalkoxy; C 1 -C 4 -haloalkylthio; SF 5 ; N,N-di-C 1 -C 4 -alkylamino-C 1 -C 4 -alkylaminocarbonyl; N—C 1 -C 4 -alkylsulfonylamino; cyano; nitro; hydroxy; B(OH) 2 ; morpholino; or phenyl, benzoyl, pyridyloxy, pyrimidinyloxy or benzothiazloyl, which is each unsubstituted or substituted by halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 3 -C 6 -cycloalkyl or C 1 -C 4 -alkoxy.

6. A compound of formula (I) according to claim 4 , wherein each R 1 is independently halogen; C 1 -C 2 -alkyl; C 1 -C 3 -haloalkyl; C 1 -C 2 -alkoxy; C 1 -C 3 -haloalkoxy; C 1 -C 2 -haloalkylthio; SF 5 ; nitro; or hydroxy.

7. A compound of formula (I) according to claim 6 , wherein r is an integer of 1, 2 or 3.

8. A compound of formula (I) according to claim 1 , wherein R 0 is H, m is 0 or 1 and X is O.

9. A compound according to claim 1 of formula

wherein R and m are each as defined in claim 1 .

10. A compound according to claim 1 of formula

wherein R, R 1 , m and r are each as defined in claim 1 .

11. A compound of formula (Ib) according to claim 10 , wherein m is an integer 1 or 2, r is an integer 2 or 3, each R is independently halogen or CF 3 , and each R 1 is independently halogen or CF 3 .

12. A composition for the control of parasites, which contains as active ingredient at least one compound of formula (I) according to claim 1 , in addition to carriers and/or dispersants.

13. A method of controlling endoparasites, on warm-blooded animals, which comprises administering to the warm-blooded animals a veterinary effective amount of at least one compound of formula (I) according to claim 1 .

Assignments (5)
CHANGE OF NAME Recorded Aug 25, 2017
From: NOVARTIS TIERGESUNDHEIT AG
To: ELANCO TIERGESUNDHEIT AG
Reel/Frame 043402/0680 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: PERRET, JEAN-LUC
To: NOVARTIS CENTRE DE RECHERCHE SANTE ANIMALE SA
Reel/Frame 038020/0136 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: GAUVRY, NOELLE; PAUTRAT, FRANCOIS; TAHTAOUI, CHOUAIB
To: NOVARTIS ANIMAL HEALTH, INC.
Reel/Frame 038020/0173 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: NOVARTIS CENTRE DE RECHERCHE SANTE ANIMALE SA; NOVARTIS ANIMAL HEALTH, INC.
To: NOVARTIS AG
Reel/Frame 038020/0198 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: NOVARTIS AG
To: NOVARTIS TIERGESUNDHEIT AG
Reel/Frame 038169/0416 →